Neurocrine Biosciences D
D
NBIX
124.400
USD
-0.67
(-0.54%)
مغلق
حجم التداول
30,156
الربح لكل سهم
5
العائد الربحي
-
P/E
42
حجم السوق
12,311,348,008
الأخبار المقالات
العنوان: Neurocrine Biosciences
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.